Starling Oncology (STLNW) Treasury Shares (2020 - 2026)

Starling Oncology (STLNW) has reported Treasury Shares for 4 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Treasury Shares changed 0.0% year-over-year to $1.0 million; the trailing twelve-month figure through Jun 2026 stood at $1.0 million (changed 0.0% YoY), and the FY2025 full-year result was $1.0 million, changed 0.0% from the prior year.
• Treasury Shares was little changed at $1.0 million in Q2 2026 per STLNW's latest filing, from $1.0 million in the prior quarter.
• Across five years, Treasury Shares topped out at $1.7 million in Q3 2023 and bottomed at $1.6 million in Q2 2023.
• Historically, Treasury Shares has averaged $1.7 million across 4 years, with a median of $1.7 million in 2023.
• The widest YoY moves for Treasury Shares: up 13.98% in 2024, down 0.0% in 2024.
• Over 4 years, Treasury Shares stood at $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025, then changed by 0.0% to $1.0 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $1.0 million, $1.0 million, and $1.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.